Macrogenics INC (MGNX) SEC Filings — 2026
2 SEC filings for Macrogenics INC (MGNX) in 2026.
Filings
- MacroGenics' Tebotelimab Study Meets Primary Endpoint — 8-K · Apr 8, 2026
- Macrogenics Files DEFA14A Proxy Materials — DEFA14A · Apr 8, 2026
2 SEC filings for Macrogenics INC (MGNX) in 2026.